Valuation: GKB Ophthalmics Limited

Market Cap 31Cr 32.46L 28.13L 26.35L 24.04L 45.19L 45.89L 3.1Cr 1.21Cr 16Cr 1.22Cr 1.19Cr 52Cr P/E 2025
-4.32x
P/E 2026 21.7x
Enterprise Value 38Cr 40.05L 34.7L 32.51L 29.66L 55.75L 56.61L 3.82Cr 1.49Cr 19Cr 1.5Cr 1.47Cr 64Cr EV / Sales 2025
0.29x
EV / Sales 2026 0.23x
Free-Float
21.95%
Yield 2025 *
-
Yield 2026 -
12/08 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
27/05 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
12/02 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/11 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
15/25/15 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
13/25/13 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/24/14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
13/24/13 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
30/24/30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
19/24/19 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
14/24/14 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
14/23/14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
1 day+5.00%
1 week+17.06%
Current month+11.21%
1 month+9.51%
3 months-0.75%
6 months+5.44%
Current year+25.88%
1 week 56.4
Extreme 56.4
64.89
1 month 55
Extreme 55
64.89
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 10/12/1981
Director of Finance/CFO - 01/04/2019
Chief Administrative Officer 62 01/06/2024
Director TitleAgeSince
Chairman 84 10/12/1981
Director/Board Member 57 24/07/1996
Director/Board Member 68 20/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
+5.00%+17.06%-13.99%-28.79% 32.46L
+0.21%-3.85%-37.11%-6.49% 8.72TCr
+0.93%+5.78%-14.82%-16.79% 3.53TCr
-0.12%+2.53%+5.56%-18.04% 1.5TCr
+2.29%+6.13% - - 1.07TCr
+2.14%+8.15%-9.05%+668.61% 230.71Cr
-0.76%+2.54%-38.78%-59.54% 155.33Cr
+0.46%+8.76%+66.30%-6.75% 92Cr
0.00%-0.26%+19.24%+10.04% 90Cr
-0.30%-0.63%-34.48%-22.15% 89Cr
Average +0.98%+3.45%-6.35%+57.79% 1.55TCr
Weighted average by Cap. +0.48%-0.73%-25.76%+0.03%

Financials

2025 2026
Net sales 108.99Cr 1.14Cr 99L 92.76L 84.61L 1.59Cr 1.62Cr 11Cr 4.26Cr 55Cr 4.29Cr 4.2Cr 181.97Cr 149.06Cr 1.56Cr 1.35Cr 1.27Cr 1.16Cr 2.18Cr 2.21Cr 15Cr 5.83Cr 75Cr 5.87Cr 5.74Cr 248.88Cr
Net income -7.04Cr -7L -6L -6L -5L -10.28L -10.44L -70.52L -27.57L -3.53Cr -27.73L -27.13L -12Cr 1.22Cr 1L 1L 1L 94.59T 2L 2L 12.2L 5L 61.01L 5L 5L 2.03Cr
Net Debt 1.56Cr 2L 1L 1L 1L 2L 2L 15.61L 6L 78.07L 6L 6L 2.6Cr 7.24Cr 8L 7L 6L 6L 10.56L 10.73L 72.46L 28.32L 3.62Cr 28.49L 27.87L 12Cr
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
156
Date Price Change Volume
13/26/13 64.50 +5.00% 4,442
12/26/12 ₹61.43 +2.40% 3,772
11/26/11 ₹59.99 +0.10% 1,383
10/26/10 ₹59.93 +2.64% 505
07/26/07 ₹58.39 +5.97% 174